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Abstract
Background: The World Health Organization (WHO) reports estimate that 85% of  newborn deaths are due to infections,
prematurity and fetal distress. These conditions are risk factors for upper GI bleeding (UGIB) in sick neonates. UGIB is
associated with poor neonatal outcomes such as prolonged hospitalisation and poor weight gain. The magnitude of UGIB
and its contribution to neonatal morbidity has not been described in most low income countries.
Objective: To determine the occurrence and factors associated with UGIB among neonates admitted to the Special Care
Unit (SCU) of Mulago Hospital.
Methods: This was a prospective single cohort study where neonates admitted within 24 hours of birth were consecutively
enrolled and followed up for seven days. Gastric aspirates from the neonates were examined daily over a period of 7 days
using Guaiac and Apt tests for evidence of  UGIB. Data on occurrence of  UGIB has been presented as proportions and
Odds Ratios for associated factors.
Results: Out of  191 neonates, 44 (23 %) developed UGIB. Factors independently associated with UGIB included cyanosis
in the neonate [OR 5.8; (95% CI; 1.8 – 19.1) p-value 0.004], neonatal seizures [OR 12.6; (95% CI 2.3 – 70.5); p-value 0.004]
and birth asphyxia [OR 6.3; (95% CI 1.9 – 21.6); p-value 0.003].
Conclusions: In the first seven days of life, UGIB occurred in 1:4 neonates. Factors independently associated with UGIB
included birth asphyxia, cyanosis in the neonate and neonatal seizures.
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Introduction
Upper GI bleeding in neonates occurs in 10 to 40%
of critically ill neonates, especially among those
suffering from infections, preterm birth,
thrombocytopenia and birth asphyxia 1-4.   This
condition is associated with poor neonatal outcomes
such as prolonged hospitalization and poor weight
gain. Most of the published studies have been
conducted in high income countries with better
neonatal care and outcomes compared to the low
income countries. The magnitude of  UGIB bleeding
and its contribution to neonatal morbidity have not
been described in most low income countries.   In
this paper we describe the occurrence of UGIB in a
neonatal unit at Mulago Hospital, Kampala, Uganda
and associated factors.
Methods
Study design and Setting
This was a prospective cohort study, conducted in
November and December 2010 at the Special Care
Unit (SCU) of Mulago Hospital. Mulago Hospital
is a national referral hospital for Uganda and the
Teaching Hospital for Makerere University.  The
SCU, which serves as the neonatal intensive care unit,
receives ill or preterm neonates of  age less than 24
hours born in or referred to Mulago Hospital.
Sample size estimation
A sample size for occurrence of UGIB of 141 was
based on a 10.2% prevalence of UGIB 3  using Keish
Leslie formula. Based on a reported association
between thrombocytopenia and UGIB5, a sample
size 173 for factors associated with UGIB was
obtained using the Fleiss formula6. Adding 10% loss
to follow up to the larger sample size of 173, a
sample size of  191 was required for the study.
Enrolment of patients
All neonates admitted to the SCU during the study
period were eligible for participation.   Those whose
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mother/caretaker provided informed consent were
enrolled. Babies born before arrival to hospital, those
who already had UGIB at admission and neonates
older than 24 hours at enrollment were excluded.
Neonates were recruited every day between 8:00 am
and 8:00pm, while those admitted after 8.00pm were
recruited the following morning. All the participants
had a detailed physical examination including gestation
age assessment using the New Ballard’s scoring
system.
Specimen collection and lab analysis
All the neonates had an NG tube gauge 5 inserted.
At least 2 ml of gastric aspirates were collected once
daily between 8-9.00 am and sent for occult blood
analysis at the Clinical chemistry laboratory. Part of
the sample from aspirates that tested positive for
occult blood was subjected to an Apt test to
determine the origin of  the blood. Peripheral blood
samples were taken for a complete blood count at
the hematology laboratory of  Mulago hospital.
Follow up
All the neonates in this study were followed up for
seven days, or until they developed UGIB, or death
or discharge or the attending doctors recommend
removal of the NG tube, whichever came first.
Data Management
Data was collected using a structured questionnaire,
entered into a database using EPI DATA 3.1 and
analyzed using STATA version 10. P-values below
0.05 were considered significant using confidence
intervals of  95%. Laboratory, maternal and infant
characteristics were compared among infants who
had UGIB versus those who did not have UGIB.
Factors with a p-value of less than 0.1 were entered
into logistic regression by backward stepwise method
and tested for confounding and interaction to the
independent variable.
Ethical considerations
Written informed consent was obtained from all the
mothers of  the participating neonates.  Approval to
carry out this study was obtained from the
Institutional Research and Ethics committee of
Makerere University Medical School, Mulago
Hospital Ethics Committee and the Uganda National
Council for Science and Technology.
Results
During the months of November and December
2010, three hundred and twenty six (326) neonates
admitted to the SCU were screened, out of which
207 were eligible. As shown in figure 1, seven eligible
neonates were excluded because 5 mothers refused
to consent and 2 babies were abandoned and had
no caretakers. A further 9 neonates were excluded
from the analysis because of missing laboratory
results. All the study subjects were less than 24 hours
old at enrollment. The mean gestational age of the
study participants was 35.0 weeks (SD 3.0) and the
mean birth weight was 2.4 kg (SD 0.8). The other
characteristics are shown in table 1.
Laboratory findings of  study subjects
Of the 191 participants, 23 had a low platelet count
of < 150,000/µL. As shown in table 2, a total of
92 neonates had a positive guaiac test in their gastric
aspirates. Out of  these 92 neonates, 44 had a negative
Apt test, indicating that the blood in the aspirates
was of neonatal origin; while 48 samples with positive
Apt test contained swallowed maternal blood.
Occurrence of UGIB
In this study, 23.0% of  the neonates followed up
developed UGIB. A majority (59.0%) of  those 44
neonates were male and 59.1% were term babies.
Factors associated with UGIB
Table 3 shows the diagnosis, clinical and laboratory
findings associated with UGIB on bivariate analysis.
As shown in table 4, factors independently associated
with UGIB include cyanosis in the neonate, neonatal
seizures and birth asphyxia.
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Figure 1: Study Profile
Table 1: Characteristics of  the 191 neonates assessed for occurrence of  UGIB








Normal(< 18 Hours) 100 52.4
Prolonged(> 18 Hours)              91 47.6
Mode of  delivery
Vaginal 136 71.2
Cesarean section                         55 28.8
HIV exposure
Not exposed 142 74.3
Exposed 33                  17.3
Unknown                                 16                    8.4
Gestation Age
Preterm( < 37wks) 102 53.4
Term( > 37wks)                         89                  46.6
Birth Weight
Low < 2.5Kg 109 57.1
Normal > 2.5Kg                       82                  42.9
Axillary temperature (oC)
Low < 35.5
Normal 35.5 – 37.5
High  > 37.5 7010912 36.757.06.3
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Continuation of table 1
Variable                        Frequency(191) Percentage(%)
Respiratory rate (breaths/min)
Low  < 40 21 0.16
Normal 40 – 59 25 5.4
High > 60 64 34.5
Pulse rate (beats/min)
Low < 100 4 2.1
Normal 100 – 160 175 91.6
High > 160 12 6.3
Apgar Score at 5 min
Low  < 7   84 44.0
Normal >7 107 56.0
Table 2: Laboratory findings of  neonates assessed for occurrence of  UGIB
Variable Frequency(191) Percentage(%)
WBC count
Low (<9,000/µL) 40 20.9
Normal (9,000 - 30,000/µL) 138 72.3
High (> 30,000/µL) 13 6.8
Hemoglobin level (g/dl)
Low (< 15g/dl) 33 17.3
Normal (> 15g/dl) 158 82.7
Platelet count
Thrombocytopenia (<150,000) 23 12.0
Normal > 150,000 168 88.0
Occult blood in gastric aspirates (Guaiac test)
Positive 92 48.2
Negative 99 51.8
Apt Test on occult blood positive gastric aspirates
Positive for swallowed blood 48 52.2
Negative 44 47.8
Discussion
In this study, almost a quarter of  the neonates
developed UGIB, a figure that lies within the range
of 5.5% - 43.5% found by various studies3, 7-10. The
prevalence in this study is less than what some studies
reported most probably because the neonates in this
study had advanced gestation age and were less likely
to be on mechanical ventilation and other invasive
procedures. A higher figure of  43.5% 2 was reported
among children diagnosed with stress ulceration,
while Deerojanawong et al reported 51.8%  in
among children on mechanical ventilation, a
recognized risk factor for UGIB5.
A closer proportion of 20% was reported by
Kuusela et al 9 while Cochran et al, found 25% of
the 208 patients followed up developed UGIB11.
Proportions as low as 6%  have been reported in
some studies12, 13 which considered a general pediatric
population. While ranitidine prophylaxis decreases
the incidence of UGIB in critically ill children9, 14, 15, it
is not known whether the prevalence in this study
would have been lower than 23.0% had the study
subjects received ranitidine prophylaxis against UGIB.
As previously reported 3, 9, 16, this study has supported
the association between birth asphyxia and UGIB.
UGIB in neonates with birth asphyxia has been
attributed to stress of illness, which is a known risk
for gastric ulceration occurring in up to 20% of
patients cared for in the neonatal ICU9. Stress increases
gastric acid secretion and plays a key role in ulceration
in older children and adults17. In this study, most of
the neonates who suffered from asphyxia were born
after prolonged labor, had a low Apgar score and
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required resuscitation by bag and mask immediately
after birth. Birth asphyxia, cyanosis in the neonate
and neonatal seizures were independently associated
with UGIB and no interaction between birth
Table 3: Diagnosis, Clinical and Laboratory findings associated with UGIB
asphyxia, seizures and cyanosis was found during
analysis. Most babies in this study developed UGIB
on the 2nd and 3rd day of  follow up.
Variable Developed UGIB NO UGIB OR(95% CI) P value
N = 44(%) N= 147(%)
Thrombocytopenia (<150,000) 10 (22.7) 13(8.8) 3.0(1.2 -7.6) 0.013
Hemoglobin level (<15g/dl) 8 (18.2) 25(17.0) 1.1(0.5 – 2.6) 0.857
Neonatal seizures 8 (18.2) 2(1.4) 15.9(3.0 – 85.5) <0.001
Respiratory Distress Syndrome 1 (2.3) 4(2.7) 1.2(0.1 – 11.1) 0.871
Birth asphyxia 26 (59.1) 42(28.6) 4.1(2.0 – 8.6) <0.001
Neonatal jaundice 6 (13.6) 16(10.9) 1.3(0.5 – 3.5) 0.617
Neonatal septicemia 2 (4.6) 11(7.5) 1.7(0.4 – 8.0) 0.498
Small for gestation age 3 (6.8) 17(11.6) 1.8(0.5 – 6.4) 0.368
Mothers age < 20 years 11(25.0) 26(17.7) 1.6(0.7 – 3.5) 0.282
Vaginal Discharge 21(47.7) 45(30.6) 2.1(1.0 – 4.2) 0.037
Malaria in Pregnancy 8 (18.2) 17(11.6) 1.7(0.7 – 4.3) 0.252
HIV exposure of the neonate 8 (18.2) 25(17.0) 1.1(0.4 – 2.6) 0.857
Prolonged labor (>18 hours) 27 (61.4) 74(50.3) 2.1(1.0 – 4.1) 0.038
Low Apgar Score at 5 min 28 (63.6) 56(38.1) 2.9(1.4 – 5.8) 0.003
Baby resuscitated by bag and mask 27 (61.4) 50(34.0) 3.1(1.5 – 6.3) 0.001
after birth
Preterm delivery(<37 weeks) 18 (40.9) 84(57.1) 1.9(1.0 – 3.8) 0.059
Hypothermia (< 35.5oC) 19 (43.2) 51(34.7) 1.4(0.7 – 2.8) 0.311
Cyanosis in neonate 8 (18.2) 10(6.8) 5.1(1.8 – 14.4) 0.001
Birth weight > 2500gm 26 (59.1) 56(38.1) 2.3(1.2 – 4.7) 0.014
Respiratory rate (>60b/min) 15 (34.1) 49(33.3) 1.0(0.5 – 2.0) 0.926
Note:
1. 92% of  the babies with birth asphyxia were term deliveries.
2. Of  the 23 study subjects with thrombocytopenia; only 10 developed UGIB. Of  these 10 subjects, 6 had
mild thrombocytopenia (100,000 – 150,000), 3 had moderate thrombocytopenia (50,000 – 100,000) and
only 1 had severe thrombocytopenia (<50,000).
Table 4: Factors independently associated with UGIB
Variable Developed COR* P value AOR*(95% CI) P value
UGIB (95% CI)
N= 44 (%)
Preterm delivery 18 (40.9) 2.0(1.0 - 3.9) 0.059 3.3(1.0 – 11.5) 0.059
(<37 weeks)
Cyanosis in neonate 8 (18.2) 5.1(1.8 - 14.4) 0.001 5.8(1.8 – 19.1) 0.004
Neonatal seizures 8 (18.2) 15.9(3.0 - 85.5) <0.001 12.6(2.3 – 70.5)
0.004
Birth asphyxia 26 (59.1) 4.1(2.0 - 8.6) <0.001 6.3(1.9 – 21.6) 0.003
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All the neonates in this study received routine vitamin
K injection on admission, a factor that could have
reduced the risk of bleeding due to deficiency of
vitamin K dependent clotting factors. In this study,
thrombocytopenia was found to occur among 12%,
of the neonates, a figure that is much lower than the
reported range of 18-35 %18-20. Similar to previous
studies1, 9, this study found that thrombocytopenia
was significantly associated with UGIB. However,
reasonable conclusions at different degrees of
thrombocytopenia could not be made, since the
number for the different levels of thrombocytopenia
were few. Christensen et al attributed
thrombocytopenia in neonates (especially ELBW) to
the effect of early onset infection, thrombi, DIC,
and severe hemorrhages19. This study however did
not establish an association between septicemia and
UGIB or between septicemia and
thrombocytopenia.  In this study, all subjects received
routine prophylactic antibiotics, an intervention that
could have reduced the prevalence of septicemia
and thrombocytopenia. While studies show that
maternal medication (aspirin, heparin, indomethacin)
increase the risk of UGIB in the neonates16, 21, this
study did not find any such association, partly because
of the small numbers since only 2 mothers were on
heparin, 2 aspirin and none on warfarin.
Conclusion
In the first seven days of life, UGIB occurred in 1 in
4 neonates admitted to SCU of Mulago Hospital.
Factors independently associated with UGIB include
birth asphyxia, cyanosis in the neonate and neonatal
seizures.
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